Public Board papers 31.03.22

Define a collaborative agreement with University of Manchester and CRUK that will enhance partnership and clinical and science relationships in preparation for the Paterson

4.3 To further integrate cancer research

between the University of Manchester and The Christie

31.3.23

DCEO/DRI

5. To provide leadership within the local network of cancer care Annual objective

Measure

Timescale

Director

Progress

5.1 Implement the GM surgical oncology Strategy 5.2 Refresh of chemotherapy delivery strategy

Sustain Mutual Aid for GM to meet system recovery plans

31.3.23

COO

31.3.23

COO

Align localisation of chemotherapy with the refreshed strategy Development of governance arrangements for delivery of trials at the outreach centres Develop Haematology Strategy in line with Manchester Cancer plans Develop further the role of the ODN in future commissioning models Support Radiotherapy service resilience across the North West.

31.3.23

COO

5.3 Development of Haematology strategy

31.3.23

COO

5.4 Implement Radiotherapy Strategy

31.3.23

COO

31.3.23

COO

5.5 Delivery of National PET Service

31.3.23 31.3.23 31.3.23

COO COO

Embed PET service provision into ICS

Sustain PET CT services to GM in line with the NC2 contract Implementation of the Cancer operating model within the ICS

5.6 Cancer System leadership

Exec Team

6. To maintain excellent operational, quality and financial performance Annual objective

Measure

Timescale

Director

Progress

Maintain a rating of 1 within the finance and use of resources oversight theme as part of the NHS System Oversight Framework Delivery of Trust profit share in line with the financial plan for TCPC and CPP

6.1 To develop and deliver our financial strategy

31.3.23

EDoF&BD

31.3.23

EDoF&BD

125